Widely read:
In a market where momentum can often be fleeting, combining it with quality helps identify stocks that are not only market favourites but also have solid fundamentals. In this story, we've screened for mid-cap companies that score high on both fronts—strong business quality and matching stock price gains.
To do this, we applied two filters: mid-cap stocks with a Quality Score above 8 (indicating sound financials) and a Momentum Score above 9 (indicating strong recent market performance). This gave us a list of 10 stocks that have both resilience and market interest backing them.
To further validate the momentum, we've included each stock's one-year return in our table. From this list, we take a closer look at Godfrey Phillips and Aavas Financiers , two companies that stand out for their business models, financial metrics and strategic positioning.
| Company | Market cap (Rs cr) | 1-year returns (%) | 5-year median ROE (%) | Debt-to-equity |
|---|---|---|---|---|
| Coromandel International | 64,007 | 94 | 27.9 | 0.0 |
| Godfrey Phillips | 39,060 | 149 | 18.2 | 0.0 |
| Narayana Hrudayalaya | 37,663 | 48 | 26.3 | 0.5 |
| Chambal Fertilizer | 27,645 | 87 | 26.9 | 0.3 |
| Astrazeneca Pharma | 22,000 | 71 | 21.8 | 0.0 |
| Aadhar Housing Finance* | 20,464 | 45 | 15.3 | 3.2 |
| Manappuram Finance | 19,658 | 24 | 20.8 | 2.9 |
| Aavas Financiers | 17,395 | 44 | 13.8 | 3.3 |
| Blue Jet Health* | 13,045 | 95 | 34.4 | 0.0 |
| Avanti Feeds | 11,702 | 71 | 17.7 | 0.0 |
|
Data as of April 22, 2025 *Blue Jet median ROE available for four years | Aadhar Housing's returns calculated since May 15, 2024 |
||||
Aavas Financiers
Aavas Financiers has built a niche for itself by serving a segment that most large lenders overlook—self-employed borrowers in India's semi-urban and rural pockets. With over 373 branches across 14 states, it focuses on small-ticket home loans, often to customers without formal income documentation. What makes Aavas a high-quality franchise is its exceptional asset quality and disciplined lending. As of Q3 FY25, its gross NPA ratio was just 1.14 per cent, while net interest margins remained comfortably above 7 per cent. Its diversified loan book and risk-based pricing allow it to maintain solid profitability even while serving a higher-risk borrower base. The company's financial health is also reflected in its healthy capital adequacy ratio of 44 per cent and a solid five-year average ROA (return on assets) of 3.5 per cent, signifying solid profit generation per rupee of assets (loans disbursed).
It is also riding a favourable macro wave. With housing demand rising in tier 2 and tier 3 towns—and policies like PMAY 2.0 gaining traction—Aavas is expanding aggressively, having added 21 branches in FY24 alone.
However, challenges remain. Competition from banks and fintechs is rising and any sharp increase in borrowing costs could squeeze margins. The stock currently trades at a P/B ratio of 4 times—about 20 per cent below its five-year median P/B.
Godfrey Phillips
Godfrey Phillips is one of India's leading tobacco companies and the exclusive manufacturer of Marlboro cigarettes. While it has experimented with ventures beyond tobacco—including pan masala, confectionery and retail chain, cigarettes remain its backbone, contributing nearly 97 per cent of its revenue.
What sets the company apart is its financial strength. It reported a last five-year median profit after tax margin of 16 per cent and return on capital employed (ROCE) of 25 per cent—numbers that reflect the high-margin, capital-efficient nature of its core business. It is debt-free and generated over Rs 200 crore in free cash flows last year. The recent rally in the stock can be traced to a surge in unmanufactured tobacco exports in FY23-24, which helped drive a 30 per cent jump in overall sales. The contribution from unmanufactured tobacco jumped from 16 per cent in FY22 to 27 per cent in FY24 in total sales.
But challenges remain. Since FY15, the company has accumulated Rs 692 crore in losses from its non-tobacco businesses and only a fraction of its Rs 3,700 crore cash pile has been reinvested into productive assets. Much of the surplus sits in mutual funds, raising concerns about capital allocation. Regulatory risks, including high taxes and advertising bans, continue to hang over the tobacco sector.
The stock currently trades at a P/E of 40 times, a steep 180 per cent premium to its five-year median, indicating that a lot of optimism may already be priced in.
Investors' takeaway
This screener brings to light mid-cap companies that not only enjoy strong financial health but also sustained market momentum. While momentum backed by fundamentals can be a compelling combination, investors must look deeper into each company's business model, capital allocation, and risk factors before drawing conclusions. As always, sustained performance and long-term strategy matter more than short-term stock price movements. Do not consider the stocks mentioned in this story as our recommendations.
Also read: Want high-growth, high-quality large caps? We have 9 of them
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
